Smead Capital Management 13F holdings, Q1 2012
Holdings as of March 31, 2012 · filings on SEC EDGAR · latest filing →
Smead Capital Management disclosed 22 US equity positions worth $165.8m in its Q1 2012 13F filing. The largest position was Smead Value Fd Inst Cl at 22.2% of the reported book, followed by EBAY and SBUX. Against the Q4 2011 filing, it opened 0 new positions, added to 2 and reduced 16 among the top 22 holdings.
What did Smead Capital Management own in Q1 2012? Top 22 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2011 |
|---|---|---|---|---|---|---|---|
| 1 | Smead Value Fd Inst Cl | 22.2% | $36.9m | 1,498,789 | -2% | reduced | |
| 2 | EBAY Ebay Inc | Consumer Cyclical | 6.6% | $10.9m | 295,496 | -1% | reduced |
| 3 | SBUX Starbucks Corp | Consumer Cyclical | 6.5% | $10.8m | 193,812 | -22% | reduced |
| 4 | Cabelas Inc | 5.9% | $9.8m | 255,858 | -0% | held | |
| 5 | WFC Wells Fargo & Co New | Financial Services | 5.0% | $8.3m | 241,736 | -1% | reduced |
| 6 | HD Home Depot Inc | Consumer Cyclical | 4.6% | $7.6m | 151,291 | -2% | reduced |
| 7 | DIS Disney Walt Co | Communication Services | 4.5% | $7.4m | 169,699 | -3% | reduced |
| 8 | Nordstrom Inc | 4.4% | $7.4m | 132,417 | -1% | reduced | |
| 9 | BEN Franklin Resources Inc | Financial Services | 4.0% | $6.7m | 53,778 | -1% | reduced |
| 10 | Accenture Ltd | 3.7% | $6.2m | 95,955 | -2% | reduced | |
| 11 | PFE Pfizer Incorporated | Healthcare | 3.6% | $6.0m | 264,436 | -2% | reduced |
| 12 | Gannett Co Inc Del | 3.6% | $5.9m | 387,598 | 35% | added | |
| 13 | Mylan Laboratories Inc | 3.4% | $5.7m | 241,111 | -0% | held | |
| 14 | Walgreen Company | 3.4% | $5.6m | 168,655 | -1% | reduced | |
| 15 | Comcast Cp New | 3.4% | $5.6m | 188,974 | -0% | held | |
| 16 | BMY Bristol-Myers Squibb Co | Healthcare | 3.3% | $5.5m | 163,888 | -2% | reduced |
| 17 | GS Goldman Sachs Group Inc | Financial Services | 3.1% | $5.1m | 40,927 | 45% | added |
| 18 | MCD Mc Donalds Corp | Consumer Cyclical | 2.6% | $4.4m | 44,483 | -2% | reduced |
| 19 | MDT Medtronic Inc | Healthcare | 2.5% | $4.1m | 104,505 | -1% | reduced |
| 20 | JNJ Johnson & Johnson | Healthcare | 2.0% | $3.4m | 51,303 | -2% | reduced |
| 21 | Smead Value Fd | 1.5% | $2.4m | 97,801 | -11% | reduced | |
| 22 | Oakmark Intl Fd | 0.2% | $291.0k | 15,078 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.